Rigel Pharmaceuticals  

South San Francisco,  CA 
United States
https://www.rigel.com/
  • Booth: 14131

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Rigel has 2 FDA approved products: 1. TAVALISSE (fostamatinib disodium hexahydrate) tablets was approved in 2018. Please visit www.TAVALISSEhcp.com to see the Full Prescribing Information to learn more. 2. REZLIDHIA (olutasidenib) capsules was approved in 2022. Please visit www.REZLIDHIAhcp.com to see the Full Prescribing Information, including Boxed WARNING to learn more.

 Products

  • Rigel Pharmaceuticals

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. 

    Rigel has 3 FDA approved products: 

    • TAVALISSE® (fostamatinib disodium hexahydrate) tablets was approved in 2018. Please visit www.TAVALISSEhcp.com to see the Full Prescribing Information to learn more 

    • GAVRETO® (pralsetinib) capsules was approved in 2020. Please visit www.GAVRETO-hcp.com to see the Full Prescribing Information to learn more 

    • REZLIDHIA® (olutasidenib) capsules was approved in 2022. Please visit www.REZLIDHIAhcp.com to see the Full Prescribing Information, including Boxed WARNING to learn more 

    ...

Categories

Cancer Types
  • Hematologic Cancers
  • Lung Cancer
    • Categories:
  • Biotechnology
  • Clinical Trials
  • Pharmaceutical
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined